Skip to main content
Log in

Les immunosuppresseurs en pratique dans les MICI

The use of immunosuppressants in the treatment of inflammatory Bowel disease

  • Vidéo-Digest / Video-Digest
  • Published:
Acta Endoscopica

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Références

  1. Beaugerie L, Seksik P, Nion-Larmurier I, Gendre JP, Cosnes J. Predictors of Crohn’s disease. Gastroenterology. 2006;130:650–6.

    Article  PubMed  Google Scholar 

  2. Colombel JF, Sandborn WJ, Reinisch W, Mantzaris GJ, Kornbluth A, Rachmilewitz D, et al. SONIC study group. Infliximab, azathioprine, or combination therapy for Crohn’s disease. N Engl J Med 2010;362:1383–95.

    Article  CAS  PubMed  Google Scholar 

  3. Toruner M, Loftus EV Jr, Harmsen WS, Zinsmeister AR, Orenstein R, Sandborn WJ, et al. Risk factors for opportunistic infections in patients with inflammatory Bowel disease. Gastroenterology. 2008;134:929–36.

    Article  PubMed  Google Scholar 

  4. Louis E et al. Infliximab discontinuation in Crohn’s disease: a prospective study. Gastroenterology 2009;136:A961.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G. Bonnaud.

About this article

Cite this article

Bonnaud, G., Moreau, J. Les immunosuppresseurs en pratique dans les MICI. Acta Endosc 40, 347–353 (2010). https://doi.org/10.1007/s10190-010-0122-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10190-010-0122-z

Navigation